Markets Stocks Economy Crypto Earnings Banking Energy
Home› Markets› Feature
Markets · Exclusive

Europe's dealmaking splits: cash buyers push ahead as PE pulls back

Europe's dealmaking splits: cash buyers push ahead as PE pulls back
Markets · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Nov 17, 2026 5 min read

European dealmaking remained active this week, but the activity tells a story of a market splitting into two speeds. On one side, Finland's Iceye made a surprise all-cash offer for Italian rocket maker Avio. On the other, private equity firm CVC said it plans to walk away from its nearly €3 billion bid for Italian ingredients group IRCA. The contrast highlights who can still get deals done—and who is hitting the brakes.

Iceye's strategic bet on space

Iceye, a Finnish company known for its satellite imaging technology, has put a cash offer on the table for Avio, an Italian manufacturer of launch vehicles. Avio is best known for its Vega rocket, which is used to carry small satellites into orbit. The bid is notable because it pairs a satellite operator with a launch provider, potentially creating a more vertically integrated player in Europe's space and defense sector.

For investors, the deal signals that strategic buyers are willing to pay up for assets that give them control over critical technology. In the space industry, having both the satellites and the rockets can reduce reliance on third parties and strengthen a company's position in a market that governments increasingly view as strategic. This is part of a broader trend where defense-adjacent technology is attracting attention, as seen in Mubadala's recent SpaceX stake, which also points to growing investor interest in private space ventures.

CVC's IRCA retreat: a sign of financing strain

Meanwhile, CVC, a major private equity firm, said it plans to abandon its planned acquisition of IRCA, an Italian company that makes ingredients for the bakery and gelato industries. The deal, valued at nearly €3 billion, has been in the works for some time. CVC's decision to walk away is a reminder that large buyouts often depend on borrowed money, and when lenders and sponsors can't agree on terms, the deal can fall apart.

Private equity takeovers typically use a mix of equity and debt, with the debt often coming from banks or private credit funds. When interest rates are high or lenders become more cautious, the cost of that debt rises, and the returns that made the deal attractive to the sponsor can quickly evaporate. Renegotiations over price, structure, or protections can drag on, and sometimes the parties simply can't reach a deal.

Gedeon Richter's pharma acquisition

Not all dealmaking is struggling. Hungary's Gedeon Richter agreed to buy Australia's Mayne Pharma for about A$604 million. This acquisition fits a pattern of pharmaceutical companies picking up specialized assets to strengthen their portfolios. Mayne Pharma focuses on generic and branded medicines, and the deal gives Richter a foothold in new markets and product lines.

This is part of a broader trend where larger companies are divesting non-core brands, and other buyers are stepping in to acquire them. For example, Gedeon Richter's purchase is a cash deal, which reduces the risk of financing falling through. In contrast, LEO Pharma's IPO plans were recently shelved because the market wasn't ready, showing that even public listings face headwinds.

What it means for investors

The contrast between Iceye's cash bid and CVC's retreat illustrates a key dynamic in today's M&A market. Cash-rich corporate buyers, especially those in strategic sectors like defense and space, can still close deals because they don't rely on external financing. Their offers are more certain, which can make them more attractive to sellers.

On the other hand, private equity firms, which often depend on leveraged loans, are finding it harder to make the numbers work. Higher borrowing costs and stricter lender demands can force them to reprice deals or walk away entirely. This matters for investors because it affects how they value potential takeover targets. If private equity becomes a less reliable bidder, the premium that markets assign to companies that might be acquired could shrink.

For everyday investors, the takeaway is that M&A activity is not uniform. Sectors with clear strategic buyers—like space tech or specialized pharma—may continue to see deals get done, even as larger leveraged buyouts stumble. This could mean more volatility in the stocks of companies that are potential targets, as the likelihood of a takeover changes.

As always, it's important to remember that M&A deals can be complex and can fall through. Investors should watch for regulatory approvals, financing conditions, and the strategic rationale behind any deal. The European market, as seen in recent trading, remains sensitive to broader economic and political factors, which can also influence dealmaking.

Looking ahead

The coming weeks will show whether Iceye's bid for Avio gains traction and whether CVC's exit from IRCA is final. Investors will also be watching for other deals in the pipeline, especially in sectors where strategic buyers are active. The two-speed M&A market is likely to persist as long as financing conditions remain tight for leveraged buyouts, while cash-rich corporates continue to pursue deals that align with their long-term strategies.

More from this story

Next article · Don't miss

Nvidia's $130B forecast calms investors after CEO Huang's exit

Nvidia guided for $130 billion in fourth-quarter revenue, beating Wall Street estimates and calming nerves after CEO Jensen Huang said he's stepping down. The outlook assumes zero data center chip sales to China, shifting focus to execution and governance.

Read the story →
Nvidia's $130B forecast calms investors after CEO Huang's exit